Pages that link to "Q36453354"
Jump to navigation
Jump to search
The following pages link to Microarray-based understanding of normal and malignant plasma cells (Q36453354):
Displaying 26 items.
- Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration (Q33564854) (← links)
- Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays (Q33577408) (← links)
- Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis (Q33748979) (← links)
- Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model (Q33862010) (← links)
- Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications. (Q34022979) (← links)
- Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. (Q34427053) (← links)
- B cells move to centre stage: novel opportunities for autoimmune disease treatment (Q34544062) (← links)
- A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines (Q34750568) (← links)
- Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. (Q35120698) (← links)
- Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytes (Q35156154) (← links)
- Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23 (Q35974921) (← links)
- Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120. (Q36075224) (← links)
- Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma (Q36499443) (← links)
- Bone marrow mesenchymal stem cells are abnormal in multiple myeloma (Q36593549) (← links)
- Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma (Q37046631) (← links)
- Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease (Q37635260) (← links)
- Cytotherapies in multiple myeloma: a complementary approach to current treatments? (Q38108819) (← links)
- Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells (Q38298483) (← links)
- Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia (Q39121590) (← links)
- Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (Q39726192) (← links)
- Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth (Q40125230) (← links)
- The transcriptional profiling of human in vivo-generated plasma cells identifies selective imbalances in monoclonal gammopathies (Q41444022) (← links)
- TLR9 ligand induces the generation of CD20+ plasmablasts and plasma cells from CD27+ memory B-cells (Q41819292) (← links)
- TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines. (Q42960413) (← links)
- Inducible expression of hyperactive Syk in B cells activates Blimp-1-dependent terminal differentiation (Q46201368) (← links)
- A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells (Q48026733) (← links)